Logo image of MRX

MAREX GROUP PLC (MRX) Stock Fundamental Analysis

NASDAQ:MRX - Nasdaq - GB00BMT7GT62 - Common Stock - Currency: USD

42.44  +0.56 (+1.34%)

After market: 42.08 -0.36 (-0.85%)

Fundamental Rating

4

Taking everything into account, MRX scores 4 out of 10 in our fundamental rating. MRX was compared to 232 industry peers in the Capital Markets industry. MRX has a bad profitability rating. Also its financial health evaluation is rather negative. MRX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MRX had positive earnings in the past year.
In the past year MRX had a positive cash flow from operations.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

MRX has a Return On Assets of 1.24%. This is in the lower half of the industry: MRX underperforms 63.36% of its industry peers.
Looking at the Return On Equity, with a value of 30.81%, MRX belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of MRX (9.43%) is worse than 62.07% of its industry peers.
MRX's Profit Margin has improved in the last couple of years.
With a Gross Margin value of 39.71%, MRX is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
MRX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 9.43%
GM 39.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, MRX has more shares outstanding
MRX has a better debt/assets ratio than last year.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.26, we must say that MRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.26, MRX is not doing good in the industry: 71.98% of the companies in the same industry are doing better.
The Debt to FCF ratio of MRX is 11.19, which is on the high side as it means it would take MRX, 11.19 years of fcf income to pay off all of its debts.
MRX has a Debt to FCF ratio (11.19) which is comparable to the rest of the industry.
MRX has a Debt/Equity ratio of 10.92. This is a high value indicating a heavy dependency on external financing.
MRX has a Debt to Equity ratio of 10.92. This is amonst the worse of the industry: MRX underperforms 90.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Altman-Z 0.26
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.09, MRX perfoms like the industry average, outperforming 49.14% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, MRX is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5B 10B 15B 20B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.41% over the past year.
MRX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 50.49% yearly.
Looking at the last year, MRX shows a quite strong growth in Revenue. The Revenue has grown by 19.81% in the last year.
The Revenue has been growing by 36.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%

3.2 Future

The Earnings Per Share is expected to grow by 12.46% on average over the next years. This is quite good.
MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.39% yearly.
EPS Next Y14.9%
EPS Next 2Y13.2%
EPS Next 3Y12.46%
EPS Next 5YN/A
Revenue Next Year13.86%
Revenue Next 2Y11.03%
Revenue Next 3Y10.39%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

MRX is valuated reasonably with a Price/Earnings ratio of 10.66.
MRX's Price/Earnings ratio is a bit cheaper when compared to the industry. MRX is cheaper than 69.40% of the companies in the same industry.
When comparing the Price/Earnings ratio of MRX to the average of the S&P500 Index (26.31), we can say MRX is valued rather cheaply.
MRX is valuated correctly with a Price/Forward Earnings ratio of 12.29.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRX indicates a somewhat cheap valuation: MRX is cheaper than 60.34% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MRX to the average of the S&P500 Index (22.06), we can say MRX is valued slightly cheaper.
Industry RankSector Rank
PE 10.66
Fwd PE 12.29
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRX indicates a rather cheap valuation: MRX is cheaper than 88.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.64
EV/EBITDA N/A
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

MRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MRX's earnings are expected to grow with 12.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y13.2%
EPS Next 3Y12.46%

More info and screens

1

5. Dividend

5.1 Amount

MRX has a Yearly Dividend Yield of 1.32%. Purely for dividend investing, there may be better candidates out there.
MRX's Dividend Yield is slightly below the industry average, which is at 8.15.
With a Dividend Yield of 1.32, MRX pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.32%

5.2 History

MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y13.2%
EPS Next 3Y12.46%
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

MAREX GROUP PLC

NASDAQ:MRX (6/5/2025, 8:00:01 PM)

After market: 42.08 -0.36 (-0.85%)

42.44

+0.56 (+1.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners44.65%
Inst Owner Change0%
Ins Owners5.89%
Ins Owner ChangeN/A
Market Cap3.02B
Analysts81.67
Price Target45.14 (6.36%)
Short Float %2.98%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 1.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date05-27 2025-05-27 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.61%
Min EPS beat(2)11.13%
Max EPS beat(2)18.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.52%
Min Revenue beat(2)2.3%
Max Revenue beat(2)8.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)17.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.32%
EPS NY rev (1m)0%
EPS NY rev (3m)12.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.88%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)7.12%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 12.29
P/S 0.95
P/FCF 2.64
P/OCF 2.6
P/B 3.09
P/tB 4.06
EV/EBITDA N/A
EPS(TTM)3.98
EY9.38%
EPS(NY)3.45
Fwd EY8.14%
FCF(TTM)16.06
FCFY37.83%
OCF(TTM)16.33
OCFY38.49%
SpS44.8
BVpS13.71
TBVpS10.44
PEG (NY)0.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.43%
GM 39.71%
FCFM 35.84%
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Debt/EBITDA N/A
Cap/Depr 69.1%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 379.93%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.26
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)453.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
EPS Next Y14.9%
EPS Next 2Y13.2%
EPS Next 3Y12.46%
EPS Next 5YN/A
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%
Revenue Next Year13.86%
Revenue Next 2Y11.03%
Revenue Next 3Y10.39%
Revenue Next 5YN/A
EBIT growth 1Y-18.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.58%
EBIT Next 3Y16.69%
EBIT Next 5YN/A
FCF growth 1Y58.2%
FCF growth 3Y35.13%
FCF growth 5YN/A
OCF growth 1Y58.3%
OCF growth 3Y35.2%
OCF growth 5YN/A